Immunoglobulin gene sequence analysis is widely utilized for prognostication in chronic lymphocytic leukemia (CLL) and the definition of standardized procedures has allowed reliable and reproducible results. Occasionally, a straightforward interpretation of the sequences is not possible because of the so-called 'problematic sequences' that do not fit the 'classic' interpretation and pose scientific questions at the cross-road between hematology and immunology. Thanks to a dedicated effort within the European Research Initiative on CLL (ERIC), we have now the possibility to present such cases, offer a scientific explanation and propose recommendations in terms of prognostication.
Introduction
In recent years, the significant increase in the understanding of the pathogenesis of chronic lymphocytic leukemia (CLL) has translated into a biologically oriented assessment of prognosis. 1 In particular, there has been a major progress in the identification of both molecular and cellular markers that may predict disease progression and assist in the rational design of risk-adapted therapies.
A milestone in CLL research came in 1999, when the Hamblin/Stevenson and Chiorazzi groups independently reported that somatic hypermutations (SHMs) present in rearranged immunoglobulin heavy variable (IGHV) genes in CLL predict a different clinical course. 2, 3 In particular, CLL patients with mutated IGHV genes generally follow a more indolent course than those with unmutated IGHV genes, who more often display advanced disease, adverse cytogenetic features, clonal evolution and resistance to therapy. Since 1999, many groups worldwide have confirmed this finding, establishing that the IGHV gene mutational status is one of the most robust prognostic markers in CLL, even independently of clinical stage.
Given the importance of the determination of IGHV gene mutational status in clinical practice, in 2007 the European Research Initiative on CLL (ERIC) published guidelines on how to perform and interpret IGHV gene mutational analysis in CLL. 4 These recommendations detailed the various steps and minimum requirements for reliable and reproducible analysis of the rearranged IGHV genes in CLL with the aim of precisely determining the actual mutational status for each individual patient. The guidelines emphasize the need for determination of the mutational status of a functional IGHV gene involved in a productive (and supposedly expressed) IGHV/immunoglobulin heavy diversity immunoglobulin heavy joining (IGHV/IGHD/ IGHJ) rearrangement, thereby requiring the amplification and sequence analysis of the entire variable heavy complementaritydetermining region 3 (VH CDR3).
The use of standardized procedures allows for direct comparison of IGHV gene sequence data between laboratories. This is critical for multicenter treatment studies in which IGHV gene mutational status is used as a criterion for patient stratification. In the vast majority of cases, the prognostic implications of IGHV gene analysis can be ascertained reliably using the 98% identity cutoff to define IGHV-mutated or IGHV-unmutated cases. Nevertheless, as for any mathematical cutoff value used for assessing a biological phenomenon, great caution is warranted when dealing with cases of 'borderline' mutational status. 4 Occasionally, a straightforward interpretation of the sequencing results is not possible because of various types of 'problems'. There are three main categories of 'problematic' cases: (1) those in which only a single unproductive IGHV/ IGHD/IGHJ rearrangement is amplified; (2) those in which double rearrangements with discordant mutational status are coamplified; and (3) those in which the VH CDR3 lacks critical residues (VH CDR3 'anchors', as defined by IMGT, the international ImMunoGeneTics Information system; 5,6 see http://imgt.cines.fr/textes/IMGTScientificChart/), which are crucial for the structural integrity of the antigen-binding loop.
In the past, such 'problematic' cases never came to the foreground, at least based on the published studies, as their cumulative frequency was apparently very low, likely because of the limited number of sequences analyzed in each single series. More recently, with the widespread and ever-increasing use of IGHV gene mutational status for clinical prognostication in CLL, with hundreds if not thousands of CLL immunoglobulin sequences being analyzed every year all over the world, the 'problematic' cases have started appearing in every series, thus creating problems for the final interpretation. This has become clearly evident thanks to the online support and trouble-shooting forum that was launched in 2007 as part of ERIC activities (http://www.ericll.org/projects/IGVHMutational Analysis.php) in order to assist the laboratories performing IGHV gene mutational analysis. This assistance is provided by a Review Board of experts who discuss the submitted queries and promptly reply with appropriate suggestions/comments. Besides technical and methodological issues, the most relevant concerns were indeed regarding 'problematic' cases where the present knowledge does not allow proper interpretation of the sequence and, ultimately, a definitive report to the clinicians.
Prompted by this experience, the members of the ERIC Review Board realized the relevance of 'problematic' cases and performed a thorough analysis of this phenomenon through a retrospective evaluation of similar cases in their collective series of 4154 CLL cases. Hence, the aim of this work was to show the significance of the issue; discuss the genetic and biological explanation of 'problematic' cases; and, finally, offer recommendations on the potential implications of these findings in terms of prognostication.
Single unproductive IGHV/IGHD/IGHJ rearrangement

Results
Unproductive IGHV/IGHD/IGHJ rearrangements may arise either by the V-D-J recombination process (that is, out-of-frame junctions, junctions carrying stop codons, utilization of pseudogenes; Figure 1 ) 7 or as a result of SHMs leading to the introduction of stop codons or out-of-frame insertions/duplications or deletions (that is, those not occurring as multiples of three nucleotides and, thus, not preserving the reading frame). 8 Among 4154 cases with CLL from collaborating institutions in France, Greece, Italy, The Netherlands, Sweden and the United Kingdom, unproductive rearrangements were detected in 377 (9.1%) cases ( Table 1) . As expected, they were significantly more frequent when genomic DNA (gDNA) rather than complementary DNA (cDNA) was used as the starting material (351/2526 (13.9%) vs 26/1628 (1.6%) cases) and, in the vast majority of cases (350/377, 92.8%), a productive rearrangement was also present. Interestingly, 27 cases (0.65% of the cohort) carried a single unproductive rearrangement (20/2526 (0.8%) and 7/1628 (0.4%) cases analyzed from gDNA and cDNA, respectively; Table 1 ). Within this subgroup, 23 rearrangements had out-of-frame junctions, 3 utilized pseudogenes, 18 carried stop codons and, finally, 6 exhibited frameshifts due to out-of-frame insertions/ duplications and/or deletions. Notably, most unproductive rearrangements carried more than one type of defect.
Explanation
The detection of single unproductive rearrangements in a B cell, especially when using cDNA for immunoglobulin analysis, raises several biological and practical questions. Single unproductive rearrangements are found at a measurable frequency in precursor B-cell neoplasms, for example, B-cell precursor acute lymphoblastic leukemia. 9 In contrast, they are very rare in malignancies of mature B cells, as the surface expression of the B-cell receptor is thought to be absolutely necessary for its survival through a tonic signaling within the cell. Therefore, the biological mechanisms that allow clonogenic progenitors lacking functional B-cell receptors to evade apoptosis are largely unknown.
Prognostic interpretation and suggestions
For practical (prognostication) purposes in CLL, the existence of single unproductive IGHV/IGHD/IGHJ rearrangements should always prompt further investigation in order to exclude the possibility that the functional productive allele has been missed during the analysis, due to technical pitfalls. Possible strategies include: (1) repeating the PCR reactions with a different set of primers; (2) if gDNA had been used as starting material, repeating the analysis using cDNA; and (3) trying again on a new sample. If, after taking all these measures, a productively rearranged allele is not amplified, it is impossible to give a conclusive statement about prognosis based on the unproductive rearrangement and this should be reported clearly to the clinician.
Double IGHV/IGHD/IGHJ rearrangements with discordant mutational status
Results Double rearrangements were identified in 435/4154 (10.5%) cases from our series (Table 1 ). Similar to normal B cells, double IGHV/IGHD/IGHJ rearrangements were significantly more frequent when the starting material was gDNA (374/2526 (14.8%)), although they were also present when using cDNA (61/1628 (3.8%)). In the vast majority of cases with double rearrangements (350/435 (80.5%)), as expected, a productive rearrangement was co-amplified along with an unproductive one. In 326/350 (93%) of such cases, both rearrangements had concordant mutational status, making the definition of mutational status straightforward as both were considered either mutated or unmutated based on the 98% identity cutoff value. The remaining cases (24/350) carried rearrangements of discordant IGHV gene mutational status. In particular, 7 cases (0.16% of the cohort) carried one mutated productive and one unmutated unproductive rearrangement and could, thus, be considered as 'mutated'; the remaining 17 cases (0.4% of the cohort) carried one unmutated, productive and one mutated, unproductive rearrangement, posing a real problem for the final determination of the mutational status (Table 1) . More interestingly, 85/435 cases with double rearrangements (19.5%) carried two productively rearranged alleles and within this subgroup, 29 cases (0.7% of the cohort) showed a discordant SHM status. The number of double productive rearrangements with discordant mutational status was similar regardless of the type of starting material (gDNA or cDNA) (14 and 15, respectively; Table 1 ).
Explanation
Double productive IGHV/IGHD/IGHJ rearrangements have been detected at both the gDNA and cDNA levels in normal as well as malignant B cells. In such cases, typically, only one rearrangement will be translated to protein and expressed on the cell surface as part of B-cell receptor because of allelic exclusion. 10 Nevertheless, lack of allelic exclusion has been reported in, for example, autoreactive B cells, 11 leading to the expression of multiple antigen receptors, probably as an attempt to edit a 'deleterious' B-cell receptor. Evidence for lack of allelic exclusion (sometimes referred to as 'allelic inclusion') has also been obtained for B-cell malignancies, in particular CLL. 12, 13 Indeed, molecular studies have suggested that allelic exclusion may not be absolute in a minority of CLL cases (with reported frequencies ranging from 1.5 to 5%) in either the heavy or the light chain loci or both, with continued immunoglobulin gene rearrangements postulated to occur in the context of (auto)antigen-driven receptor editing. 12, 13 Occasionally, the presence of double productive IGHV/ IGHD/IGHJ rearrangements may reflect the existence of biclonal populations in the same patient. Along these lines, it has been reported that up to 5% of patients with B-cell chronic lymphoproliferative malignancies may display two or more clonal populations.
14 In such cases, if two separate tumor populations are indicated by flow cytometry, biclonality can be conclusively proven only after identification of the light chain sequence(s) at the molecular level.
Interpretation
In CLL cases with double IGHV/IGHD/IGHJ rearrangements of concordant mutational status (that is, both mutated or Immunoglobulin sequence analysis and prognostication in CLL AW Langerak et al both unmutated), the mutational status can be easily defined and reported to the clinician (regardless of whether both rearrangements are productive or whether one is productive and the other unproductive). The situation is still relatively easy to interpret when a productive mutated IGHV/IGHD/IGHJ rearrangement is co-amplified along with an unproductive unmutated one. Such cases may confidently be assigned to the IGHV-mutated subgroup on the reasoning that the productive rearrangement is also the one expressed on the cell surface, thereby the functional clonotypic rearrangement whose mutational status may underlie the biological and clinical behavior of the CLL clone. If both rearrangements are productive and exhibit discordant IGHV gene mutational status, it is impossible to give a conclusive, prognostically relevant interpretation. Although admittedly rare (29/4154 cases of the present study, 0.7%), this situation could create problems, especially if this biomarker is used for risk stratification within clinical trials.
A similarly problematic situation arises if a case carries one unmutated productive and one mutated unproductive IGHV/ IGHD/IGHJ rearrangement. This is even less frequent (17/4154 cases of the present study, 0.4%) but still poses a problem that is also difficult to solve, at least for prognostication purposes. Based on our data, in the majority of such cases, the 'unmutated' productive rearrangement still bears some evidence of mutational activity, that is, is o100% identical to the germline. From a biological standpoint, there are data to suggest that low mutational load in CLL productive rearrangements (leading to a germline identity of X98% but o100%) may have been functionally selected, perhaps providing the clone with certain antigenic reactivities. [15] [16] [17] The unproductive rearrangement would have been similarly targeted by the SHM process but remained free of any functional constraints and thus left to acquire significantly more mutations of a random nature. Whatever the underlying explanation for this phenomenon, at present, a prognostically relevant interpretation is lacking. Therefore, its clinical implications will remain unknown until more data are available.
To summarize, in cases carrying two productive rearrangements of discordant mutational status or carrying one unmutated productive in combination with one mutated unproductive rearrangement, it is currently not possible to offer a conclusive interpretation. This should be reported clearly to the clinician in order to avoid a potentially harmful misinterpretation. A possible exception could be cases carrying a rearrangement of the IGHV3-21 gene. As in most studies this gene has been correlated with a poor clinical outcome, [18] [19] [20] [21] [22] [23] cases with double rearrangements of which one is mutated productive and employs the IGHV3-21 gene could be considered as having unfavorable prognosis, in particular when showing a stereotyped VH CDR3.
Missing VH CDR3 anchor
Results and explanation
In rare cases, the residues critical for ensuring the integrity of VH CDR3 (VH CDR3 anchors), that is, IMGT 2nd-CYS 104 and J-TRP 118, 24 are missing because of either IGHV or IGHJ gene trimming by exonucleases during V-D-J recombination or introduction of SHM (Figure 1) . The functionality of rearrangements lacking either one or both of these anchors is currently unknown. Such rearrangements have rarely been found in repertoires from normal, autoreactive or malignant B cells, including CLL. In the present series, 18 cases carried an in-frame rearrangement with the absence of 2nd-CYS 104 or J-TRP 118 (9 each from gDNA and cDNA amplification).
Interpretation
In such cases, the analysis should be repeated in an attempt to amplify a second rearrangement, as previously mentioned. However, if an altered codon 118 is followed by a conserved Gly-X-Gly (G-X-G) motif (IMGT positions 119-121) in the FR4 encoded by the IGHJ gene, 24, 25 it can be assumed that the rearrangement is productive and can be used for interpretation of the mutational status. Furthermore, if flow cytometry analysis demonstrates the presence of surface immunoglobulin, the rearrangement might be considered as encoding for a functional polypeptide, although formal proof of this assumption would require in vitro biosynthesis experiments.
ERIC database of problematic cases
At the end of 2006, ERIC launched an online support tool (www.ericll.org/projects) for CLL cases with IGHV/IGHD/IGHJ sequences that were difficult to interpret. This tool has been recognized and employed by many researchers worldwide. As of November 2010, overall, 79 enquiries have been submitted to the ERIC Review Board for feedback on interpretation of difficult cases and/or troubleshooting on technical issues. A breakdown of all the requests into different categories is shown in Table 2 .
Apart from technical (no or truncated sequences) and methodological (PCR protocol, primers, use of different databases for sequence interpretation) issues, requests were submitted to gain insights into VH CDR3 stereotypy or the clinical implications of cases with IGHV/IGHD/IGHJ sequences exhibiting: (1) borderline somatic mutational status; (2) insertions and/ or deletions; and (3) intraclonal diversity.
Besides these, many requests concerned 'problematic' cases with respect to the interpretation of IGHV gene mutational status, as defined on the ERIC website (http://www.ericll.org/ projects/IGVHMutationalAnalysis.php). The largest category of submitted problematic cases concerned CLL cases with a single unproductive IGHV/IGHD/IGHJ rearrangement; in such cases, the starting material was, variably, gDNA or cDNA. The general advice in such cases was to repeat the PCR reactions with different primer sets in order to try and find the productively rearranged allele.
The second group of requests was on CLL cases with double productive IGHV/IGHD/IGHJ rearrangements, which could be split into those with similar or discordant IGHV gene mutational status. For the latter subgroup, which poses the real interpretation problem, it was advised to report them as inconclusive; for gDNA-based analyses, a suggestion was given that repeating the test using cDNA might shed more light on the truly productive allele, thus enabling interpretation.
Another subgroup of requests concerned single IGH rearrangements that are basically productive, but that lack one of the anchor positions of the VH CDR3, that is, 2nd-CYS 104 or J-TRP 118. The advice of the Board was that the impact of this alteration on proper folding and antigen binding of such rearrangements is currently unknown, although the presence of the G-X-G motif in FR4 or the presence of surface immunoglobulin may be indicative of functionality, as mentioned above.
Taken together, the online support tool has provided a valuable platform for guidance on both technological and methodological issues and interpretation of sequences, as well as for initiating the creation of a database for relatively rare categories of problematic interpretations that will eventually assist in drawing biologically and prognostically meaningful conclusions.
Conclusions
Following the ERIC recommendations for IGHV gene mutational analysis and interpretation in CLL, the vast majority of cases will be confidently defined as either IGHV gene-mutated or geneunmutated based on a precise germline identity score. That notwithstanding, a small minority of cases (B2%) will remain 'problematic', hindering definitive conclusions with prognostic relevance. The underlying reasons may vary; however, they can be broadly assigned to three categories (Table 3) : (1) single unproductive rearrangement; (2) double IGHV/IGHD/IGHJ rearrangements with discordant mutational status; and (3) missing VH CDR3 anchor(s).
It is important to make scientists involved in the assessment of the IGHV gene mutational status aware of the existence of such cases and of the fact that the biological and clinical implications of such 'problems' are currently unknown. This is mainly because of their rarity, thus hampering a meaningful investigation at the single institution level. Creating awareness will help to establish multi-institutional collaborations that are strongly needed with the aim to create a large collection of wellannotated cases, eventually enabling to perform an extended analysis and to reliably explore potential clinicobiological correlations. 
